Renowned Physician Reveals Findings of 18 Months of Research Regarding COVID-19
Los Angeles, CA, February 8, 2022 — Since January 2020, authors Peter R Breggin, M.D., and Ginger Ross Breggin worked fulltime for 18 months, examining what they call the “real” science surrounding COVID-19 and criticizing “the fraudulent science used to justify the suppression of personal and political liberty throughout the world.”
They reveal their findings in their new book, COVID-19 and the Global Predators: We Are the Prey.In it, they document what they term “the shocking corruption behind the pandemic catastrophe.” The Breggins detail “the motivations, conflicts of interest and deceitful collaborations of the major players behind draconian pandemic policies,” leading to what they describe as “the suppression of our personal freedoms.” They uncover what they say is the2015-2016 master plan created by Bill Gates and Klaus Schwab working with leading health officials in the U.S., the U.N. and WHO, as well as billionaires, international corporations and Chinese Communist officials.
The Breggins also expose what they claim is Anthony Fauci’s role in the pandemic, including his funding of gain-of-function research creating SARS-CoV pathogens in collaboration with China. They share the currently reduced standards for drug and vaccine approval by the FDA. They highlight their findings that inexpensive, effective and safe treatments for COVID-19, such as hydroxychloroquine and Ivermectin, are often suppressed in order to promote the vaccines. The government’s rampant fear mongering and totalitarianism disguised as public health policies, the authors say, “are fueling the demise of our health, our democracy and our freedom.”
The book has separate introductions by three of the world’s leading COVID-19 physicians: Peter McCullough, M.D, M.P.H.; Vladimir "Zev" Zelenko, M.D.; and Elizabeth Lee Vliet, M.D. The book has strong endorsements from Robert F. Kennedy Jr. and Paul Alexander, Ph.D., former consultant to the White House Coronavirus Task Force and the World Health Organization, who says its “depth and reach is beyond reproach . . . the most detailed, scientific and rational analysis to date . . . stunningly comprehensive and broad.”
Robert F. Kennedy Jr. had this to say: “No other book than COVID-19 and the Global Predatorsso comprehensively covers the details of COVID-19 criminal conduct as well as its origins in a network of global predators seeking wealth and power at the expense of human freedom and prosperity, under cover of false public health policies.”
COVID-19 and the Global Predators concludes with hopeful and inspiring messages, a call to courage, and examples and guidance about how readers can retake their freedom personally and politically. The Breggins conclude, “We must revive our trust in each other. We must strengthen our belief in loving one another and in supporting each other’s liberty.”
About the Authors
Peter R. Breggin, M.D., is a lifelong reformer, called “The Conscience of Psychiatry” for his criticism of biological psychiatry and his advocacy for effective, empathic and ethical forms of psychological, educational and social approaches to emotional and psychological distress. He graduated from Harvard College with Honors, and his psychiatric training included a Teaching Fellowship at Harvard Medical School. He then became a fulltime consultant at the National Institute of Mental Health (NIMH). Since then, he has taught at several universities, including Johns Hopkins, George Mason, the University of Maryland and the Washington School of Psychiatry. He has been a medical expert in over 100 trials, many related to scientific issues in this book, and is now an expert in COVID-19 cases. He has authored 70 scientific articles, plus many medical books and bestsellers, including Talking Back to Prozac with his wife, Ginger Breggin.
Ginger Ross Breggin is also a lifelong reformer. She has been an editor of newspapers and magazines, and has a background in publishing and public relations. She has been Dr. Breggin’s partner in all his reform work since they married in 1984. She has coauthored or coedited four of his 20-plus books, including Talking Back to Prozac, which sold almost one million copies, and has helped develop and edit several others. In 2009, she edited and published The Conscience of Psychiatry: The Reform Work of Peter R. Breggin, MD, based on testimonials and media reports about her husband’s first 54 years (1954-2009) of efforts to improve his profession and to advocate for the rights of patients. Ginger manages most of their outreach and keeps in touch with innumerable individual leaders and groups involved in the treatment of COVID-19 and the movement to reinspire and to rescue freedom throughout the world.
For more information, please visit their website at www.breggin.com. Their weekly radio/TV show is available on brighteon.tv and Roku, and their videos are available on brighteon.com.
COVID-19 and the Global Predators: We Are the Prey
Dying to Survive: Not in Vain, A Promise Kept ExploresLife and Death Impact of Patient Advocacy
New York, NY, Feb. 8, 2021 — They were killing her mother with negligence, Melissa Mullamphy recalls. And eight months later, Mullamphy’s mother succumbed following a cancer battle fraught with frustration, medical missteps and the endless bureaucracy that goes hand in hand with navigating our complex healthcare system.
Not in Vain, A Promise Kept isMullamphy’s candid account of her mother’s journey and the family’s roller coaster of emotions. Readers will witness the mistakes that compounded their pain, the small victories that gave them hope, and above all, the love that kept them going during an indescribably difficult time.
Each chapter in Not In Vain, A Promise Kept represents one month from her mother’s diagnosis to her passing. Mullamphy recalls the experiences with vivid detail (the names of doctors and nurses have been changed), hoping to prompt others to ask the tough questions and learn by her example.
“My goal in writing this book is to keep the promise that I made to my mom … to share her story so others don’t go through what she and my family went through,” Mullamphy says. “You can have input, control and make a difference in your loved one’s healthcare.”
Mullamphy shares shocking lapses in her mother’s care, including blood clots the doctor fails to notice, the confusion surrounding her mother’s DNR order, the time she found her mother wearing another patient’s bracelet and the unspeakable heartbreak of learning that that all along, the hospital had used the wrong type of chemotherapy drug for her mother’s specific cancer.
Not In Vain, A Promise Kept is not without moments of hope, such as when the family is told the tumor has shrunk and when her mother’s last-ditch surgery to remove the tumor is declared “wildly successful.”
Ultimately, Not In Vain, A Promise Kept pays homage to a life well-lived and a woman well-loved, and it’s Mullamphy’s aim to help other patients and their loved ones find their voices, understand their rights and learn how to navigate a deeply complex, imperfect healthcare system.
“Use your voice, and remember that you are not there to make friends,” she adds. “Sometimes you have to be the biggest mouth in the room, but speaking up can save your loved one’s life.”
Author Melissa Mullamphy has a master’s degree in clinical psychology and has worked in psychiatric emergency rooms and step-down houses. Forever a student of mental health, she has also worked with many nonprofits, including those benefiting military veterans. For almost 20 years, she worked as a domestic operations manager for a major corporation. Following her experience with her mother’s cancer diagnosis and treatment, she began blogging about current events as they relate to healthcare.
Seek Change and Align with Your Highest Purpose Using Tools Outlined in The Change Guidebook
“The Change Guidebook is an exceptional tool for creating positive change and adapting to life’s challenges.” — former U.S. Senator Olympia J. Snowe
Portland, ME, February 9, 2022 — Many of us know we need a change, an overhaul of the way we “do” life. We feel the need to move forward, but we aren’t sure where to place our feet to take those first steps.
The Change Guidebook from Elizabeth Hamilton-Guarino, founder of The Best Ever You Network, ends the search for self-help that works, serving as a life-long companion guide and resource to complement your life. It offers 10 points for making a change or adapting to unforeseen circumstances, and allows you to become a change master by using the provided solutions to change, grow and become your bravest and boldest self. These points are a process that you can engage in and turn to in times of need, crisis, or to alter your life’s course.
“The extreme demands of our modern world constantly challenge our alignment. I passionately believe that nearly everything revolves around our ability to manage our time and how we make or deal with change. Our attitude in how we approach each moment provides the insight to cherish them all with gratitude, no matter the happenings," Hamilton-Guarino says. "I wrote this book from my heart, truths and energy to yours to help you feel and be your best. As I share my own obstacles and victories in my life, I also welcome over 20 other contributors, who have also taken the time to share their stories with the world.”
By using the tools provided within this book, readers will experience the joy of living life as someone firmly grounded in values, anchored by a consistent moment-to-moment practice of gratitude. These principles have been widely used to achieve goals from changing careers to weight loss, becoming a college athlete, and more, and have been proven to change many lives.
About the Author Elizabeth Hamilton-Guarino is the founder of The Best Ever You Network and co-founder of Compliance4. Through these companies, she has helped individuals and organizations around the world be their best and achieve world-class excellence with gratitude-based behavior and belief systems. She is one of America's foremost personal and corporate development consultants specializing in mindset, strategy, leadership and taking action.
Elizabeth is also the author of the award-winning personal development book Percolate: Let Your Best Self Filter Through (Hay House) and multiple children’s books as a contributor and author. Elizabeth and her husband live in Maine with their four sons, two dogs and three rescued cats. Visit her website at besteveryou.com.
The Change Guidebook Publisher: HCI Books Release Date: March 8, 2022 ISBN-10: 0757324215 ISBN-13: 9780757324215 Trade Paperback, 224 pages Available for pre-order wherever books are sold
###
LifeLabs ranked in the top 100 of Canada’s Best Employers of 2022 by Forbes
This is the second consecutive year for LifeLabs to achieve the recognition of being one of Canada’s best employers.
Toronto, Ontario, Feb. 09, 2022 (GLOBE NEWSWIRE) -- We are pleased to share that LifeLabs has been named one of “Canada’s Best Employers for 2022” by Forbes. In addition to being recognized for the second consecutive year, LifeLabs has also placed in the top 100, out of 300 employers. This prestigious award is presented by Forbes and Statista Inc., the world-leading statistics portal and industry ranking provider.
“As an organization, it is an honour to be recognized by our employees and peers as an employer of choice,” says Charles Brown, President and CEO of LifeLabs. “We thank each of our employees for embodying LifeLabs’ values daily, making significant contributions to our communities and the healthcare sector. They are the driving force of what we do in our pursuit of excellence and to empower healthier Canadians.”
Despite navigating through the challenges of the COVID-19 pandemic, LifeLabs’ placement for this award significantly improved from the previous year, from a ranking of 190 to 75.
Forbes in partnership with market research firm, Statista, surveyed more than 10,000 Canadians working for businesses with at least 500 employees to rank the list of 300 employers. Participants were asked to rate their willingness to recommend their own employers to friends and family, as well as nominating organizations other than their own.
To learn more about this award and to see the complete list, please visit the Forbes website.
About LifeLabs
LifeLabs is Canada’s leading provider of laboratory diagnostic information and digital health connectivity systems, enabling patients and health care practitioners to diagnose, treat, monitor, and prevent disease. We support 20 million patient visits annually and conduct over 100 million laboratory tests through leading edge technologies and our 6,000 talented and dedicated employees. We are a committed innovator in supporting Canadians to live healthier lives, operating Canada’s first commercial genetics lab, and the country’s largest online patient portal, with more than 5 million Canadians receiving their results online. LifeLabs is 100% Canadian owned by OMERS Infrastructure, the infrastructure investment manager of one of Canada’s largest defined benefit pension plans. Learn more at lifelabs.com.
Top NYC Doc Preventing Blindness in People of Color
New York, NY, February 9, 2022— Glaucoma is the leading cause of blindness in African Americans and people from the Caribbean, but there is a simple way to prevent the devastating effects of glaucoma: Don’t skip your eyecare visits, advises Dr. Daniel Laroche, Director of Glaucoma Services and President of Advanced Eyecare of New York.
What is Glaucoma? Glaucoma is a disease of the eye characterized by three components:
1. Damage and loss of the retinal ganglions cells and optic nerve described as cupping
2. Loss of visual field
3. Usually increased eye pressure (the mean normal eye pressure is 15mmHG)
In most cases of glaucoma, there is no pain, and the loss of vision occurs slowly from peripheral to central. Many people do not even realize it’s happening until they have lost a substantial amount of peripheral vision.
People at risk for glaucoma include the elderly, Black people, people with elevated eye pressure, primary relatives with glaucoma, persons with high myopia, high hyperopia, history of eye trauma and diabetes.
Early cataract surgery and trabecular bypass have become the best options to stop vision loss in patients with glaucoma. The current use of eyedrops and laser help to lower intraocular pressure but do not address the causative mechanism of the glaucoma being the enlarged lens. Incisional cataract surgery and glaucoma surgery is often needed to truly stabilize glaucoma.
All people should be screened regularly for glaucoma as part of a medical eye exam that includes gonioscopy (examination of the drainage angle), intraocular pressure measurement with Goldmann applanation tonometry and a dilated optic nerve examination. If there appears to be any damage to the optic nerve or abnormal pressure, then a visual field test should be performed, and optic nerve photos taken. Persons with thin corneas should be more aggressively monitored and treated for glaucoma as the disease tends to be worse in these patients.
If you have eye pressure or glaucoma and feel that you may be losing vision, Dr. Laroche recommends that you seek the care of a glaucoma specialist for a second opinion. DON’T GO BLIND FROM GLAUCOMA! People with conditions such as glaucoma and diabetic retinopathy that could lead to blindness if left unchecked need to stay particularly vigilant with checkups.
“Eyesight or human vision is one of the most important senses,” Dr. LaRoche says. “As much as 80 percent of what we feel comes through our sense of sight. By protecting the eyes, people will reduce the chance of blindness and vision loss while also staying on top of any developing eye diseases, such as glaucoma and cataracts.”
About Dr. Daniel Laroche
Dr. Laroche is an exceptional glaucoma specialist in New York. He studied and received his bachelor's degree from New York University and a medical doctorate with honors in research from Weil Cornell University Medical College. He underwent a medical internship at Montefiore Hospital and finished his ophthalmology residency at Howard University Hospital in Washington D.C., where he was the chief resident in his third year. He later completed his glaucoma fellowship at New York Eye and Ear.
Dr. Laroche is also the author of the new young adult book, How to Become a Successful Black Man, which educates and empowers young boys and men of African descent about their history, heritage and legacy. Dr. Laroche connects history to the present-day life experiences and challenges of the Black Man to instill self-confidence and personal growth to succeed. The book helps to address health and wealth disparities and can be ordered here: https://www.amazon.com/How-Be-Successful-BlackMan/dp/0578841770/ref=sr_1_2?dchild=1&keywords=daniel+laroche&qid=1623702468&sr=8-2.
###
Candid New Book Exposes Damage Done by Bad Boss Behaviors
Tempe, AZ, Feb. 9, 2022 — If you recognize aspects of your own misguided management tactics between the covers of How to Tell if You’re an A**Hole Boss, you are the problem! But it’s never too late to course-correct, advises veteran HR consultant Tamica Sears.
“I’m here to walk you through a self-discovery process that will make you not just a better boss but also a better leader and a better person,” Sears proclaims. “Sometimes, the truth hurts, but nothing good comes from ducking reality.”
An HR professional with more than 20 years of experience, Sears has analyzed and mediated situations involving a broad spectrum of management behaviors. In How to Tell if You’re an A**Hole Boss, she pulls no punches while breaking down the good, the bad and the ugly using fictionalized stories based on real-life encounters with difficult bosses.
Along the way, she provides actionable tips and tools for engaging with teams, retaining top talent, creating healthy work environments and much more. Even managers with excellent track records will find that Sears’ wisdom will help them boost their own levels of performance and effectiveness.
Discussions focusing on the clues to bad behavior such as, “You Enter a Room, and People Stop Talking,” or, “Your Employees Seem Pissed Off All the Time for No Reason,” populate the book and are intended to spur self-reflection.
How to Tell if You’re an A**Hole Boss, a humorous yet brutally honest book for bosses brave enough to glance in the mirror, offers a path to corrective redemption and is applicable to anyone who aspires to a position of authority within any organization.
“Changing your behavior is entirely up to you,” Sears emphasizes. “But if you do have the will to pursue a more productive path, read this book and it’ll definitely help you create a better future for you, your family, your team and your company.”
About the Author
Tamica Sears, known as The Corporate Fixer, is an HR Consultant and Executive Coach on a mission to save corporate America. With 20 years of human resources, leadership development and coaching experience, she helps leaders become more inclusive, empathetic, innovative and authentic. She has successfully guided organizations through mergers and acquisitions, organizational restructures, strategy sessions and succession planning, and has created and implemented effective leadership development programs. Her philosophy: HR professionals should be employee advocates focused on giving employees the best workplace experience possible.
Identifying self-esteem as a common issue with many leaders, in 2018 Sears published You Are Enough, a book of motivational quotes designed to increase self-awareness and improve self-esteem in 30 days. A frequent guest on podcasts and featured at workshops and conferences, Sears enjoys speaking on leadership development, the future of work, DE&I, and self-awareness.
How to Tell if You’re an A**hole Boss: A Humorous, Yet Honest Exposé on Misguided Management Behaviors
Publisher: Storymakers, Inc.
Release Date: February 2022
ISBN-13: 978-0-9888079-8-3
Available from Amazon.com and through all major book distributors globally
###
Canadian Ophthalmological Society highlights potential new treatments of eye disease during AMD Awareness Month
Clinical trials underway for promising new therapies that aim to enhance the treatment of age-related macular degeneration
TORONTO, Feb. 8, 2022 /CNW/ - Age-related macular degeneration (AMD) is one of the leading causes of blindness in Canada, affecting nearly 2 million Canadians today. As February marks AMD Awareness Month, the Canadian Ophthalmological Society is helping to spread awareness by highlighting the work of Canadian ophthalmologists who are involved in research for promising new therapies that aim to enhance the treatment of "wet" AMD, which is the more severe type of the eye disease.
"At first, you may not notice changes in your vision but as AMD progresses to advanced stages, you may experience blurred vision that may start to appear as a large dark spot, while straight lines might look wavy or distorted," says Dr. Colin Mann, President of the Canadian Ophthalmological Society. "While there is no cure, the good news is that comprehensive eye exams can show if you're at risk of AMD and provide early detection and treatment if needed."
Promising AMD research is being done on many fronts with clinical trials well underway. A number of global Phase 3 clinical trials are assessing new therapies with the goal of increasing durability, reducing treatment burden, and achieving improved efficacy and safety. More options means that patients can have access to "individualized" treatments, as certain therapies may affect and work better for different patients. Applications for some of these therapeutics have already been submitted to Health Canada for review and approval.
"While very effective, many patients require frequent monitoring and treatments, which becomes a challenge for long term care of AMD," says Dr. Varun Chaudhary, Chief of Ophthalmology & Professor of Surgery at McMaster University. "If approved, the groundbreaking therapies being tested in Phase 3 trials could lead to improved outcomes for patients by providing durable options that can significantly reduce the treatment burden on patients."
Additional exciting news for AMD include clinical trials for geographic atrophy – a currently untreatable form of AMD which leads to significant vision loss. These trials are demonstrating some early positive signals and long term data is being collected. In addition, rapid advancements in imaging technologies are allowing eye care specialists to diagnose patients with early membranes of wet AMD before patients develop symptoms. These patients are at much higher risk of requiring treatment within the next year or two, and monitoring schedules can be adjusted to ensure close follow-up and early treatment which is vital for preserving vision in the long term.
There are also important developments in technologies that could allow patients undergoing treatment to use home equipment with data relayed directly to their eye care professional. In addition, advances in artificial intelligence are allowing developments of models that can predict how different patients will respond to treatment, which may allow more personalized treatment options in the future.
AMD affects the central vision and occurs when cells in the macula – a small area of the retina located at the back of the eye – break down or deteriorate. While peripheral vision is not affected, one loses the sharp, straight-ahead vision that is necessary for driving, reading, recognizing faces, and looking at fine detail. According to the Canadian Ophthalmological Society, AMD accounts for 90 per cent of new cases of legal blindness in the country.
While age is the most significant risk factor for developing AMD, you may be more likely to develop AMD if you have one or more of the following:
Blue eyes
High blood pressure
Heart disease
High cholesterol
Smoker
Overweight
Frequently eat foods high in saturated fat (e.g., butter, cheese)
Family history of AMD
Check your vision using the Amsler grid and learn more about AMD, or one of the other four serious eye diseases, by visiting seethepossibilities.ca.
About Canadian Ophthalmological Society The Canadian Ophthalmological Society (COS) is the national, recognized authority on eye and vision care in Canada. As eye physicians and surgeons, we are committed to assuring the provision of optimal medical and surgical eye care for all Canadians by promoting excellence in ophthalmology and by providing services to support our members in practice. Our membership includes over 900 ophthalmologists and 200 ophthalmology residents. We work collaboratively with government, other national and international specialty societies, our academic communities (ACUPO), our provincial partners and affiliates and other eye care professionals and patient groups to advocate for health policy in Canada in the area of eye and vision health. The COS is an accredited, award-winning provider of Continuing Professional Development (CPD) through the Royal College of Physicians and Surgeons of Canada (RCPSC) and is an affiliate of the Canadian Medical Association (CMA). For more information, visit cos-sco.ca.
SOURCE Canadian Ophthalmological Society
Canada’s Wonderland to open April 30, with plans to hire approximately 4,000 associates for the 2022 season
VAUGHAN, ON, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Planning for the 2022 season at Canada’s Wonderland is underway and the amusement park has announced it will open to the public on Saturday, April 30. In preparation for the upcoming season, the park has launched its recruitment campaign to fill thousands of positions across all departments.
“We may be in the depths of winter, but we’re already looking ahead to the brighter, warmer days of spring when we can welcome guests back for the 2022 season,” said Norm Pirtovshek, general manager. “Hiring has begun and there are many great jobs available. Working here is fun for obvious reasons and comes with great benefits, but we also value professional growth and leadership development which makes Canada’s Wonderland the perfect place to launch a career.”
Food Service Associates and Line Cooks (minimum age to apply is 15 years old)
Lifeguards (minimum age: 16)
Ride Operators (minimum age: 18)
Maintenance (including Landscaping and Mechanical Technicians)
Security
Guest Services
Entertainment (Roaming Musicians, Character Performers and Show Hosts)
Both seasonal and full-time positions are available. Canada’s Wonderland is committed to fostering a workplace culture in which diversity, equity and inclusion are embraced and promoted. Associate benefits include free and unlimited use of the park and water park during off hours, free promotional tickets for friends and family, access to exclusive employee events and activities throughout the season, discounts to partnering Ontario attractions, employee discounts on food, merchandise and more.
The park continues to work closely with provincial and regional health officials and will provide updates to its COVID-19 safety protocols closer to opening day.
Canada’s Wonderland, located in Vaughan, Ontario (just outside Toronto), is a 300-acre theme park with more than 200 attractions including 17 roller coasters, and is the home to Splash Works, a 20-acre water park. Canada’s Wonderland is owned and operated by Cedar Fair Entertainment Company (NYSE: FUN), a publicly traded partnership and one of the largest regional amusement-resort operators in the world. The Company owns and operates 11 amusement parks, four outdoor water parks, an indoor water park and resort accommodations totaling more than 2,300 rooms and more than 600 luxury RV sites. For more information, see www.cedarfair.com.
Breaking the Rules with Galaxy Tab S8 series: Our Biggest, Boldest, Most Versatile Galaxy Tablets Yet
The Galaxy Tab S8 Ultra joins the Samsung tablet portfolio – offering powerful performance, a truly immersive display, and seamless ecosystem connectivity
MISSISSAUGA, Ontario, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Today, Samsung Electronics Canada announced its new Galaxy Tab S8 series, which includes the Galaxy Tab S8 and Galaxy Tab S8+, and the first-ever Galaxy Tab S8 Ultra tablet with our biggest, boldest display yet and the most powerful performance Galaxy Tab S has ever offered. Sophisticated hardware, premium productivity features, and seamless Galaxy ecosystem connectivity – are all combined in a single portable powerhouse that is designed to be your perfect companion in an always-on, video-first world. The Galaxy Tab S8 series offers you the freedom and flexibility you deserve to work and play on the go.
Now, we rely on tablets for video calls and streaming. Each Galaxy Tab S8 series device offers an improved video conferencing experience with ultra-wide front cameras, a three-microphone setup, and intelligent auto-framing1. The tablets offer revolutionary multitasking capabilities with enhanced Multi-active Windows2 and Samsung DeX, file-sharing with password-protected Quick Share3, powerful productivity with the new super-fast 4nm processor, and a smoother S Pen included in the box4. All of this is packed into the thinnest and toughest Armor Aluminum5 body yet for greater portability, and enhanced your mobile experience. The Galaxy Tab S8 series works hand-in-hand with your full ecosystem of Galaxy devices, thanks to features like Second Screen and Buds Auto Switch6.
“As we rely more on videos to stay connected and entertained, we know that a tablet’s most compelling feature is its large screen and portability,” said TM Roh, President & Head of MX Business at Samsung Electronics. “We built on years of innovation in mobile experiences to refine the Galaxy Tab S8 series, and to push the boundaries of what’s possible on a tablet with the first Galaxy Tab S8 Ultra.”
Expand Your World with the First Galaxy Tab S8 Ultra The Galaxy Tab S8 Ultra offers a premium tablet experience that is unlike any Galaxy Tab before it. With its expansive 14.6-inch Super AMOLED display and 120Hz refresh rate, it also boasts the thinnest bezels yet on a Galaxy tablet at 6.3mm for a maximum screen-to-body ratio and a truly immersive experience. Its gorgeous display is protected by an Armor Aluminum frame, making it over 30% more scratch-resistant and 40% less prone to bending than its predecessor.7 With premium technology you can take just about anywhere, the Galaxy Tab S8 Ultra is built to fully immerse you in every video, movie, game and more, on-the-move.
Equipped with powerful dual 12MP front cameras, the Galaxy Tab S8 Ultra also transforms your video call experience with professional 4K video quality. Advanced hardware meets software with Samsung auto-framing technology that automatically keeps you in focus during a call, while also zooming in or out to include new participants as they join you. You’ll also sound as clear as you look, thanks to three precision microphones that use advanced noise reduction technology to prevent unwanted background chatter. Quad Speakers with Dolby Atmos®, found on all three Galaxy Tab S8 series models, ensure that everything sounds incredible and clear.
Work, Play and Connect Whether you want to explore your artistic side, be immersed in lag-free gaming, or simply multitask with ease, the Galaxy Tab S8 series is the tablet you need for unbeatable performance. Equipped with the first 4nm chip – the fastest processor ever in a Galaxy Tablet – Galaxy Tab S8 and Galaxy Tab S8+ also provide ample RAM and storage for any task. If you need more, the Galaxy Tab S8 Ultra can expand to 12 GB of RAM and up to 256 GB of storage, and all three models offer expandable storage of up to 1 TB with an optional microSD8 card.
The Galaxy Tab S8 series is also the first Samsung tablet to support Wi-Fi 6E9, which provides up to double the bandwidth10 and maximum speed of Wi-Fi 6. With optimized network quality you don’t have to worry about weak connections.
With Galaxy Tab S8, you’ll always be ready for action, fueled by an intelligent all-day battery that supports hours of video playback11 when you’re in the middle of a movie marathon. It supports 45W super-fast charging that can get you back to 100% in just 80 minutes1213. The incredible fast-charging battery on the Galaxy Tab S8 can double as a portable charger14. Simply connect your Galaxy S22 series smartphone using a USB-C cable.
The Galaxy Tab S8 Ultra and Galaxy Tab S8+ both come with a new and improved S Pen that delivers an incredible writing experience that mimics gliding a pen across paper thanks to its ultra-low latency15.
Galaxy Tab S8 Ultra boasts new 4K recording capabilities now allow you to capture crisp, eye-catching videos with both the rear camera and ultra-wide front camera. Content creators and streamers can effortlessly create online tutorials and gameplay, using customizable Selfie Videos16 that are now embedded within Samsung’s Screen Recorder.
The expansive display on the Galaxy Tab S8 Ultra makes it easy for you to split the screen into multiple, resizable windows, so you can multitask without having to toggle between apps. Get inspired, search websites, and annotate presentation slides — all in one view.
Tablets also play an important role in keeping you connected to others. Samsung has partnered with Google for even better video calling and live sharing experiences through Google Duo17; so, you can co-watch videos with your friends on YouTube, share your browser to help plan your next meetup, or develop creative ideas using JamBoard18, Google’s interactive whiteboard.
Life Opens Up with Galaxy The Galaxy Tab S8 series performs seamlessly with the entire Galaxy ecosystem. We’ve ensured that the Samsung One UI Tab 4 user interface offers you a consistent and intuitive experience, seamless connectivity as well as smart integrations that flow from your Galaxy Tab S8 to smartphone and PC.
When inspiration strikes on the go, use the S Pen to jot down reminders in the new and improved Samsung Notes app on the Galaxy Tab S8 series and pull them up on your smartphone later for easy reference. And with the Galaxy Tab S8 series and Galaxy S22 Ultra, Quick Share enables you to share photos, videos, and files between devices twice as fast19 as its predecessor. Thanks to Auto Switch, your Galaxy Buds will automatically connect from your Galaxy Tab S8 to your Galaxy S22, so you can move between devices without missing a beat. And for the first time, the Samsung Health app is available on Galaxy tablets so you can browse fitness videos for workout content and keep track of your wellness and fitness data from your Galaxy Watch on a larger screen.
The Galaxy Tab S8 can be turned into a portable second monitor20 with touchscreen capabilities for Galaxy PCs for side-by-side multitasking. Samsung DeX21 – a convenient desktop experience that takes the Galaxy Tab S8 from tablet mode to desktop mode – now allows for transparent app windows and DeX mirroring for when you want to share your tablet’s screen on an external display.
A Tablet You Can Trust and Feel Good About In today’s always-connected world, security is more important than ever, which is why the Galaxy Tab S8 series boasts new features that allow you to track when your tablet’s camera and microphone are in use, giving you the option to instantly block all app access to prevent unwanted recording. The Galaxy Tab S8 series is also protected by the industry-leading Samsung Knox Vault platform, which encrypts personal data and keeps stored files and information isolated from the device’s main operating system to safeguard it from attacks. All members of the lineup sport an intuitive fingerprint scanner22 that enables single-touch device unlocking.
Standout Sustainable Design The Galaxy Tab S8 Ultra comes in bold and timeless Graphite, while Galaxy Tab S8+ comes in three sophisticated shades, Graphite, Silver and Pink Gold. Galaxy Tab S8, in Graphite and Pink Gold. Samsung is also releasing a new Galaxy Tab S8 Ultra Book Cover Keyboard23 that takes the Ultra’s functionality even further with wider, backlit keycaps, customizable shortcut settings, and adjustable standing angles. The optional Book Cover Keyboard features premium, polyurethane leather and a glass-coated touchpad that enables smooth and responsive typing. Plus, Wireless Keyboard Share24 can link your connected keyboard to a Galaxy smartphone for easy typing across devices.
You also have plenty of ways to express your personal style with distinctive Galaxy Tab S8 accessories and add-ons. Those include a transparent Note View Cover that enables handwriting with S Pen, even while the cover protects the screen, and an eye-catching Strap Cover to hold your Galaxy Tab S8 in the orientation that suits you best.25
Samsung is also proud to help reduce ocean-bound plastic and protect the planet, with the Galaxy Tab S8 series partially constructed using plastic components repurposed from discarded fishing nets. Samsung is helping lead the industry by employing this practice. The Galaxy Tab S8 series devices also come in our slimmest packaging to date, made from sustainably-sourced paper, which enables the company to lower emissions, and produce less waste.
Availability The Galaxy Tab S8 series will be available for pre-order beginning February 9, 10AM EST, and for purchase starting February 25, 2022, at Samsung.ca, Samsung Experience Stores and major retailer partners across Canada.
Gift with Purchase Offers From February 9 to February 24, 2022, Canadians who pre-order a Galaxy Tab S8 series tablet online at Samsung.com/ca or at a Samsung Experience Store location will receive a free Book Cover Keyboard Slim and Galaxy Buds2 (Graphite) as a gift with purchase.26
Purchase a Galaxy Tab S8 series tablet between February 25 and March 31, 2022, on Samsung.com/ca, or at a Samsung Experience Store location and receive a free Book Cover and Galaxy Buds2 (Graphite) as a gift with purchase.27
Trade-In Offer
From February 25 to March 31, 2022, customers who purchase a Galaxy Tab S8 series device at a Samsung Experience Store in Canada or online at Samsung.com/ca and participate in the trade-in program will receive an instant promotional trade-in credit of $100, plus the residual value of their trade-in device, applied upfront towards the purchase of their new Galaxy Tab S8 series device28
AIR MILES® Offers From February 9 to February 24, 2022, customers who pre-order and complete their purchase of an eligible new Galaxy Tab S8 series device at a Samsung Experience Store or online at Samsung.com/ca will receive:29
100 Bonus Miles with the pre-order of a Galaxy Tab S8.
200 Bonus Miles with the pre-order of a Galaxy Tab S8+.
300 Bonus Miles with the pre-order of a Galaxy Tab S8 Ultra.
From February 25 to March 4, 2022, customers who purchase a Galaxy Tab S8 series device at a Samsung Experience Store or online at Samsung.com/ca will receive:30
50 Bonus Miles with the purchase of a Galaxy Tab S8.
150 Bonus Miles with the purchase of a Galaxy Tab S8+.
250 Bonus Miles with the purchase of a Galaxy Tab S8 Ultra.
Peace of Mind with Samsung Care+ With a Samsung Care+ Plan, Canadians can experience a total care service for their new Galaxy Smartphone, Laptop, Tablet or Wearable device. Users will be protected for up to two years against physical or liquid damage and mechanical malfunction or defects, with a team of dedicated Galaxy experts available to help them get back on track.31
Canadians who pre-order a Galaxy Tab S8 series device on Samsung.com/ca between February 9, 2022 and February 24, 2022, will receive 50% off Samsung Care+ coverage.32
From February 25 to April 4, 2022, customers purchasing an eligible Galaxy Tab S8 series device can also purchase a Samsung Care+ 2 year plan for their new device for 30% off.33
Until April 4, 2022, customers who purchase Samsung Care+ for an eligible new Galaxy Tab S8 series device at a Samsung Experience Store in Canada or online at Samsung.com/ca will also receive 100 Bonus Miles.34
Door to Door Repair Service Across Canada Enjoy convenient pick-up, speedy repair, and contactless delivery to your home. If you need service support for your Samsung devices, you can arrange convenient Door-to-Door service pick-up through 1-800-SAMSUNG, Live Chat or text us at WECARE (932 273). Customers can also request a self-service repair and book simply through the Your Service portal found online at www.samsung.com/ca/galaxy-repair to arrange a convenient Door-to-Door device pick-up to their home. Pick-up and return of the Galaxy device is free of charge. Service is available for both In- and Out-of-Warranty customers. Coverage may vary. For more information on Door to Door Repair Service, please visit: https://www.samsung.com/ca/galaxy-repair
For more information about the latest Samsung Galaxy devices including specifications: www.samsung.com/ca/.
Device Specifications:
Galaxy Tab S8
Galaxy Tab S8+
Galaxy Tab S8 Ultra
Display
11-inch, 2560x1600, (WQXGA) 276ppi LTPS TFT, up to 120Hz
12.4-inch, 2800 x 1752, (WQXGA+) 266ppi Super AMOLED, up to 120Hz
14.6-inch, 2960 x 1848, (WQXGA+) 240ppi Super AMOLED, up to 120Hz
* Measured diagonally as a full rectangle without accounting for the rounded corners. Actual viewable area is less due to the rounded corners and camera hole.
OS
Android 12.0
Dimensions
165.3 x 253.8 x 6.3mm
185.0 x 285.0 x 5.7mm
208.6 x 326.4 x 5.5mm
Weight
503g
567g
726g
Camera
Rear
13MP AF + 6MP Ultra-Wide (Dual) + Flash
Front
12MP (Ultra-Wide)
12MP (Wide) + 12MP (Ultra-Wide)
Memory & Storage
8GB + 128/256GB, microSD up to 1TB*
12GB + 256GB, microSD up to 1TB*
*MicroSD card sold separately.
Processor
4 nm 64-bit Octa-Core Processor
Battery*
8,000mAh (typical) Super Fast Charging 2.0(up to 45W)
10,090mAh (typical) Super Fast Charging 2.0(up to 45W)
11,200mAh (typical) Super Fast Charging 2.0(up to 45W)
* Typical value tested under third-party laboratory condition. Typical value is the estimated average value considering the deviation in battery capacity among the battery samples tested under IEC 61960 standard. ** Chargers sold separately.
Connectivity
Wi-Fi 6E ((802.11 a/b/g/n/ac/ax), Wi-Fi Direct Bluetooth® v 5.2
Colour*
Graphite &Pink Gold
Graphite, Silver & Pink Gold
Graphite
Connectors
Type-C USB 3.2
Sensors
Accelerometer, Geomagnetic, Gyro, Light, Fingerprint, Hall Sensor
GPS
GPS+GLONASS, Beidou, Galileo
Sound
Quad Stereo Speakers with Sound by AKG, Dolby Atmos®
Microphone
3 Microphones
Video
Recording
4K @ 30fps
Playback
8K @ 60fps
Security
Samsung Knox including Samsung Knox Vault
Biometric Authentication
Fingerprint with Side Key
Fingerprint On Display
Fingerprint On Display
Accessories
S Pen (BLE, Inbox) Book Cover Keyboard, Book Cover Keyboard Slim, Book Cover, Protective Standing Cover, Note View Cover, Strap Cover
S Pen (BLE, Inbox) Book Cover Keyboard, Book Cover, Protective Standing Cover
* S Pen and USB Type-C cable included inbox. Other accessories are available for purchase separately. Availability of third-party cases may vary by market, carrier and retailer.
*All functionality, features, specifications and other product information provided in this document including, but not limited to, the benefits, design, pricing, components, performance, availability and capabilities of the product are subject to change without notice. Specifications vary by markets and/or carriers.
________________________ 1Currently available on Samsung Camera, BlueJeans, Google Duo, Meta Messenger, Google Meet, New Knox Meeting, Microsoft Teams, Cisco Webex Meet, Zoom. Auto-framing only available on ultra-wide front camera. Auto-framing only recognizes people and may not support certain resolutions and ratios. Certain functions may not be available when Auto-framing is on. 2Not all applications may be compatible for this feature. 3Quick Share available on Galaxy smartphones and tablets with Android OS version 10.0(Q) and One UI 2.1 or above. Bluetooth Low Energy and WI-Fi connection are required for Quick Share use. Not all applications may be compatible for this feature. 4S Pen is included with Galaxy Tab S8 Series. 5Armor Aluminum is cased on all metal components, excluding the display, side keys, and the SIM tray. 6Auto Switch feature only available on Samsung Galaxy smartphones and tablets with OneUI 3.1 or later and Galaxy Watch4 Series or later. Certain devices and applications may not support Auto Switch. 7Compared to Galaxy Tab S7. Based on laboratory testing. 8MicroSD card sold separately. 9Wi-Fi 6E network availability may vary by market, network provider and user environment. Requires optimal connection. Will require a Wi-Fi 6E router. 10Double speed for Wi-Fi 6E measured for devices while using Quick Share. Compared to speed on Galaxy Tab S7 (Wi-Fi 6). Actual bandwidth and speed may vary by market, carrier, and user environment. Available on devices running One UI 2.1 or above including Galaxy Tab S8, Tab S8+, Tab S8 Ultra, S22, S21 Ultra, and Z Fold3. 11Based on average battery life under typical usage conditions. Actual battery life depends on factors such as network, features selected and other application-usage patterns. Results may vary. 1245W charger sold separately 13When using the included charger and cable. Based on average battery life under typical usage conditions. Actual battery life depends on factors such as network, features selected and other application-usage patterns. Results may vary. 14When using the included charger and cable. Based on average battery life under typical usage conditions. Actual battery life depends on factors such as network, features selected and other application-usage patterns. Results may vary. 15Compared to Galaxy Tab S7. Latency speed of 2.8ms measured for Tab S8 Ultra(14.6’’) and Tab S8+(12.4’’) models when using Samsung Notes. 16Selfie Video within Screen Recorder supports full HD video recording and playback. 17 Google Duo is a trademark of Google LLC. Live sharing host is available to Galaxy S22 series and Galaxy Tab S8 series users at time of launch and will be provided to other Galaxy device users with Android S OS at a later date. Participants may need to upgrade to the latest Google Duo app to use live sharing. Google Duo app availability may vary by market. Requires optimal network connection. 18Jamboard needs to be downloaded separately. Additional functions may require purchase. 19Compared to speed on Galaxy Tab S7 (Wi-Fi 6). Based on laboratory testing. Double speed requires both devices to have Quick Share and Wi-Fi 6E and to be connected to a Wi-Fi 6E router. Quick Share available on Galaxy smartphones and tablets with Android OS version 10.0(Q) and One UI 2.1 or above. Quick Share requires Bluetooth Low Energy and WI-Fi connection. Not all applications may be compatible for this feature. 20Second Screen feature supported for Galaxy Book Windows PC and Galaxy Tab S7/7+ or later models. (2021 Jan update required for Galaxy Tab S7/S7+) Wireless display-capable Windows 10 PC models and Windows 10 v.2004 or later version are required. (Windows update: Sep 2020 or later) 21Samsung DeX supported on select Galaxy smartphones and tablets. Additional features available on compatible devices only including Galaxy S22, Galaxy Tab S8 and devices running One UI 4.1 or above. Compatible apps may vary and not all apps may be resizable on Samsung DeX. Accessories for external screen connection sold separately. 22Galaxy Tab S8+ and Tab S8 Ultra have on-screen fingerprint scanners. Galaxy Tab S8 has a side-mounted fingerprint scanner. 23Book Cover sold separately, does not include S Pen. 24Wireless Keyboard Sharing is available on Galaxy Tab S8/S8+/S8 Ultra and select Galaxy smartphones, running One UI 4 or above. The smartphone should support Bluetooth HID profile. Both devices must be logged into the same Samsung account. Performance may vary depending on user network environment. 25Availability of covers and accessories may vary by device model and market. Covers and accessories are sold separately. 26Some conditions apply. Offer is valid from February 9th to February 24th, 2022. Pre-order from a participating authorized Canadian retailer any eligible Samsung Galaxy Tab S8/S8+/S8 Ultra and receive both a Galaxy Tab S8/S8+ Book Cover Keyboard Slim or Galaxy Tab S8 Ultra Book Cover Keyboard and a Galaxy Buds2 Graphite as a bonus (Book Cover Keyboard Slim EF-DT630BBEGCA regular price $219.99, Book Cover Keyboard Slim EF-DT730BBEGCA regular price $279.99, Book Cover Keyboard EF-DX900BBEGCA regular price $459.99, Galaxy Buds2 SM-R177NZKAXAC regular price $189.99) upon completion of your Galaxy Tab S8/S8+/S8 Ultra purchase.
Eligible Samsung Galaxy TabS8/S8+/S8 Ultra tablets are as follows:
Savings will be realized upon completion of your Galaxy Tab S8/S8+/S8 Ultra purchase. While supplies last. No rain checks. Limit of one Galaxy Tab S8/S8+/S8 Ultra Book Cover Keyboard and one Galaxy Buds2 per Galaxy Tab S8/S8+/S8 Ultra purchased. The exact model of the Book Cover Keyboard or Book Cover Keyboard Slim received by the customer will depend on the eligible Samsung Galaxy Tab S8/S8+/S8 Ultra purchased by the consumer. Open to Canadian residents only. Participating authorized Canadian retailers may vary and may sell for less. Purchases made at Samsung Experience Stores in Canada and samsung.com/ca are also eligible for this promotion. Cannot be combined with any other offer or promotion. Promotion may be cancelled or changed without notice. 27Some conditions apply. Offer is valid from February 25th to March 31st, 2022. Purchase from a participating authorized Canadian retailer any eligible Samsung Galaxy Tab S8/S8+/S8 Ultra and receive both a Galaxy Tab S8/S8+/S8 Ultra Book Cover and Galaxy Buds2 Graphite as a bonus (Book Cover EF-BT630PBEGCA regular price $99.99, EF-BT730PBEGCA regular price $109.99, EF-BX900PBEGCA regular price $149.99, Galaxy Buds2 Graphite SM-R177NZKAXAC regular price $189.99)
Eligible Samsung Galaxy Tab S8/S8+/S8 Ultra tablets are as follows:
Optimi Health Dealer’s License Granted by Health Canada
Optimi Health to become a global leader in all-natural psilocybin production
VANCOUVER, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to report that Optimi Labs Inc., a wholly-owned subsidiary of Optimi Health Corp, been granted a Dealer’s License by Health Canada.
The Dealer’s License allows for possession, production, assembling, sale, and delivery of psilocybin within the regulated framework set forth by Health Canada. Optimi will now launch vertically integrated operations at its facility in Princeton, B.C. Once fully commercialized, Optimi’s purpose-built, 10,000 sq. ft. EU GMP-compliant research and production facility will be dedicated to cultivating, extracting, and processing the highest-grade all-natural psilocybin in North America. Guiding Optimi’s stringent research and drug development process, the Company’s GMP and EU-GMP-compliant facility will expand its domestic and global reach in compliance with Health Canada regulations and favourable international regulatory regimes.
“This is a proud and exciting moment for all of us at Optimi,” exclaimed Bryan Safarik, COO and Director of Optimi. He continued, “We purposely overbuilt this facility surpassing clean room pharma grade specifications, allowing us to grow and process the purest, most consistent, safest, and efficacious mushrooms in the industry. I have always believed in our ability to be a Canadian leader in the production of natural-grade psilocybin, so I am truly grateful for all the hard work, insight, and continued effort to get this world-class facility commissioned.” Safarik also praised Health Canada’s leadership role in working with Canadian drug producers as they continue to expand the science and safety of therapeutic psilocybin mushrooms through research and clinical trials.
As noted in the recently filed annual financials, as of September 30, 2021, $8,586,465 CAD in cumulative expenditures were incurred in connection with the construction of the combined 20,000 sq. ft. facilities. Optimi’s Dealer’s License EU GMP-compliant facility contains an impressive Region III, Schedule 8 security level vault capable of securing 1,250kg of psilocybin which carries an approximate value of $53MM CDN. Other features include an Argus environmental control system which provides software and hardware features for real-time monitoring and optimization, advanced HVAC equipment and controls, fire suppression, clean room technology, 700KW backup electrical power systems, robust chain-link fencing with smart system technology including perimeter intrusion detection, wireless gate access and magnetic locks.
Optimi is poised to become the only large-scale Canadian manufacturer, and the premier supplier, of all-natural psilocybin therapies to patients, research groups, universities, licensed clinics and holders of other Dealer’s Licenses and Section 56 exemptions in Canada. While the prescription model of psilocybin delivery is dependent on further clinical trial data from the industry, Optimi will be able to supply patients by way of their physicians and the Special Access Program today. The Company has begun outreach to potential psilocybin clients in Canada and is actively seeking commercial opportunities for its products in select markets with favourable regulatory regimes.
With Health Canada’s recent amendment of the Special Access Program, physicians will be able to request patient access to restricted psychoactive substances like psilocybin and MDMA for psychedelic-assisted therapy. Optimi is taking an active leadership role in finding solutions for the ongoing Canadian mental health crisis, including access to psilocybin for therapeutic purposes. Furthermore, Optimi is committed to being proactive concerning education about the safety and efficacy of psychedelic medicines and this is exemplified through its initial phase 1 dosing study.
“Optimi is focused on providing safe, pure and reliable psychedelic products for all those in need,” said Bill Ciprick, CEO. “Achieving our approved Dealer’s License is a significant milestone in our journey to becoming a leader in the psychedelic industry. We look forward to providing further communications over the coming weeks as production begins, and our 2022 growth strategy is deployed.”
Additionally, Optimi will host an official ribbon-cutting event, late spring, to showcase its state-of-the-art facility and team leadership. The event will be coordinated around all public health protocols established during that time to ensure the health and safety of everyone involved.
On Behalf of the Board of Directors,
Bill Ciprick Chief Executive Officer Optimi Health Corp.
ABOUT OPTIMI (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN)
Optimi is developing a sophisticated mushroom brand that focuses on the health and wellness markets. With a vertically integrated approach, Optimi intends to cultivate, extract, process and distribute high quality functional and psychedelic mushroom products at its two facilities comprising a total of 20,000 square feet nearing completion in Princeton, British Columbia. To fully investigate the science of mushrooms, the Company has received a research exemption under Health Canada Food and Drug Regulations (FDR) for the use of Psilocybin and Psilocin for scientific purposes via its wholly owned subsidiary Optimi Labs Inc. Optimi has also been granted a dealer’s license under Canada’s Narcotic Control Regulations governing possession, distribution, sale, laboratory analysis of and research and development of Psilocybin and Psilocin formulations. Optimi is committed to expert cultivation and quality production subject to and in accordance with the terms of all applicable laws and governing regulations to ensure safe, superior Canadian fungi production. Find out more at: https://optimihealth.ca/.
This news release contains forward‐looking statements and forward‐looking information within the meaning of Canadian securities legislation (collectively, "forward‐looking statements") that relate to Optimi’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result," "are expected to," "expects," "will continue," "is anticipated," "anticipates," "believes," "estimated," "intends," "plans," "forecast," "projection," "strategy," "objective," and "outlook") are not historical facts and may be forward‐looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward‐looking statements. No assurance can be given that these expectations will prove to be correct and such forward‐looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. In particular and without limitation, this news release contains forward‐ looking statements pertaining to activities proposed to be conducted under the Company’s dealer’s license and associated business related to Psilocybin and Psilocin and Optimi’s plans, focus and objectives.
Forward‐looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Optimi’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward‐looking statements. Such risks and uncertainties include, but are not limited to, the impact and progression of the COVID‐19 pandemic and other factors set forth under “Forward‐Looking Statements" and “Risk Factors” in the Company’s Annual information Form dated January 12, 2022, and other continuous disclosure filings available under Optimi’s profile at www.sedar.com. Optimi undertakes no obligation to update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for Optimi to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward‐looking statement. Any forward‐looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
